Androgens activate mitogen‐activated protein kinase signaling: Role in neuroprotection
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent evidence indicates that testosterone is neuroprotective, however, the underlying mechanism(s) remains to be elucidated. In this study, we investigated the hypothesis that androgens induce mitogen‐activated protein kinase (MAPK) signaling in neurons, which subsequently drives neuroprotection. We observed that testosterone and its non‐aromatizable metabolite dihydrotestosterone (DHT) rapidly and transiently activate MAPK in cultured hippocampal neurons, as evidenced by phosphorylation of extracellular signal‐regulated kinase (ERK)‐1 and ERK‐2. Importantly, pharmacological suppression of MAPK/ERK signaling blocked androgen‐mediated neuroprotection against β‐amyloid toxicity. Androgen activation of MAPK/ERK and neuroprotection also was observed in PC12 cells stably transfected with androgen receptor (AR), but in neither wild‐type nor empty vector‐transfected PC12 cells. Downstream of ERK phosphorylation, we observed that DHT sequentially increases p90 kDa ribosomal S6 kinase (Rsk) phosphorylation and phosphorylation‐dependent inactivation of Bcl‐2‐associated death protein (Bad). Prevention of androgen‐induced phosphorylation of Rsk and Bad blocked androgen neuroprotection. These findings demonstrate AR‐dependent androgen activation of MAPK/ERK signaling in neurons, and specifically identify a neuroprotective pathway involving downstream activation of Rsk and inactivation of Bad. Elucidation of androgen‐mediated neural signaling cascades will provide important insights into the mechanisms of androgen action in brain, and may present a framework for therapeutic intervention of age‐related neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sun, M., Yang, L., Feldman, R. I., Sun, X.-M., Bhalla, K. N., Jove, R., Nicosia, S. V., & Cheng, J. Q. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306295200 · Cited by 171 · cited 1×
“(2005) 94, 1639–1651 inositol 3-kinase (PI3K)/Akt (protein kinase B) signaling via the AR (Sun et al. 2003), as well as utilize second messenger systems such as cyclic adenosine 3¢,5¢-monophosphate (Rubin et al. 1999), inositol 1,4,5-trisphosphate (Lieberherr and Grosse 1994), phospholipase C…”
MethodRetractedSpecificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132 · cited 12×
“(b) Cultures were treated with PD98059, U0126, or vehicle (VEH), followed 2 h later by treatment with 10 nM testosterone or DHT, then 2 h later exposed to 50 lM Ab25–35.”
BackgroundMethodInfluentialZha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595 · cited 2×
“In its unphosphorylated state, Bad binds to anti-apoptotic proteins (e.g. Bcl-xL, Bcl-2) and/or displaces pro-apoptotic proteins (e.g. Bax), yielding a net decrease in Bcl-2-mediated cell viability (Zha et al. 1996).”
BackgroundSimerly, R. B., Swanson, L. W., Chang, C., & Muramatsu, M. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902940107 · Cited by 2,118
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Self-citationTranslating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113 · cited 9×
“For example, androgens activate MAPK/ERK signaling via the AR and estrogen receptor (Kousteni et al. 2001) and phosphatidyl- 2005 International Society for Neurochemistry, J. Neurochem.”
BackgroundInfluentialKousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 746
Singer, C. A., Figueroa-Masot, X. A., Batchelor, R. H., & Dorsa, D. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02455.1999 · Cited by 577
Toran-Allerand, C. D., Guan, X., MacLusky, N. J., Horvath, T. L., Diano, S., Singh, M., Connolly, E. S., Nethrapalli, I. S., & Tinnikov, A. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08391.2002 · Cited by 548
Watters, J. J., Campbell, J. S., Cunningham, M. J., Krebs, E. G., & Dorsa, D. M. (1997) · Endocrinology · doi:10.1210/en.138.9.4030 · Cited by 490
Qiu, M.-S., & Green, S. H. (1992) · Neuron · doi:10.1016/0896-6273(92)90033-a · Cited by 472
Singh, M., Sétáló, G., Guan, X., Warren, M., & Toran-Allerand, C. D. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01179.1999 · Cited by 470 · cited 1×
“…and progesterone generally parallel our observations with androgens in terms of inducing modest levels of ERK phosphorylation (Singer et al. 1999; Singh et al. 1999) that are typically (Watters et al. 1997; Toran-Allerand et al. 2002) but not always (Purves-Tyson and Keast 2004) more robust for…”
BackgroundSelkoe (1999) · doi:10.1038/19866 · Cited by 468
The NMDA Receptor Is Coupled to the ERK Pathway by a Direct Interaction between NR2B and RasGRF1
Krapivinsky, G., Krapivinsky, L., Manasian, Y., Ivanov, A., Tyzio, R., Pellegrino, C., Ben-Ari, Y., Clapham, D. E., & Medina, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00645-7 · Cited by 438 · cited 2×
“2000), synaptic plasticity (Krapivinsky et al. 2003), and memory processes (Alonso et al.”
BackgroundPike, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721552.x · Cited by 387
Self-citationRegulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase
Scheid, M. P., Schubert, K. M., & Duronio, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31108 · Cited by 384
Free testosterone and risk for Alzheimer disease in older men
Moffat, S. D., Zonderman, A. B., Metter, E. J., Kawas, C., Blackman, M. R., Harman, S. M., & Resnick, S. M. (2004) · Neurology · doi:10.1212/wnl.62.2.188 · Cited by 383
Rapid Actions of Steroid Receptors in Cellular Signaling Pathways
Cato, A. C. B., Nestl, A., & Mink, S. (2002) · Science's STKE · doi:10.1126/stke.2002.138.re9 · Cited by 369
pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167
Joel, P. B., Smith, J., Sturgill, T. W., Fisher, T. L., Blenis, J., & Lannigan, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1978 · Cited by 345
Nilsen, J., & Brinton, R. D. (2002) · Endocrinology · doi:10.1210/en.143.1.205 · Cited by 342
Alonso, M., Vianna, M. R. M., Depino, A. M., Mello e Souza, T., Pereira, P., Szapiro, G., Viola, H., Pitossi, F., Izquierdo, I., & Medina, J. H. (2002) · Hippocampus · doi:10.1002/hipo.10035 · Cited by 339 · cited 1×
“The MAPK/ERK pathway has diverse functions in brain, including proliferation (Bajetto et al. 2001), neuronal differentiation (Qui and Green 1992), development (Sala et al. 2000), synaptic plasticity (Krapivinsky et al. 2003), and memory processes (Alonso et al. 2002).”
BackgroundTestosterone‐mediated neuroprotection through the androgen receptor in human primary neurons
Hammond, J., Le, Q., Goodyer, C., Gelfand, M., Trifiro, M., & LeBlanc, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00345.x · Cited by 310 · cited 6×
“Indeed, testosterone and related androgens attenuate cell death induced by b-amyloid (Ab) (Pike 2001), oxidative stress (Ahlbom et al. 2001), and serum deprivation (Hammond et al. 2001).”
BackgroundInfluentialChen, R. H., Abate, C., & Blenis, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10952 · Cited by 298
Lieberherr, M., & Grosse, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37270-8 · Cited by 275 · cited 4×
“…al. 2003), as well as utilize second messenger systems such as cyclic adenosine 3¢,5¢-monophosphate (Rubin et al. 1999), inositol 1,4,5-trisphosphate (Lieberherr and Grosse 1994), phospholipase C (Benten et al. 1999), 1,2-diacylglycerol (Lieberherr and Grosse 1994), and calcium (Wunderlich et al.…”
BackgroundInfluentialBrain aromatase is neuroprotective
Azcoitia, I., Sierra, A., Veiga, S., Honda, S., Harada, N., & Garcia‐Segura, L. M. (2001) · Journal of Neurobiology · doi:10.1002/neu.1038 · Cited by 273
Rapid signalling by androgen receptor in prostate cancer cells
Peterziel, H., Mink, S., Schonert, A., Becker, M., Klocker, H., & Cato, A. C. (1999) · Oncogene · doi:10.1038/sj.onc.1203032 · Cited by 271 · cited 6×
“The rapid and transient ERK phosphorylation pattern observed in our neurons is similar to observations of androgen-mediated ERK signaling in prostate cancer cells (Peterziel et al. 1999) and osteocytes (Kousteni et al.”
BackgroundResultInfluentialAhlbom, E., Prins, G. S., & Ceccatelli, S. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03155-3 · Cited by 262 · cited 3×
“Indeed, testosterone and related androgens attenuate cell death induced by b-amyloid (Ab) (Pike 2001), oxidative stress (Ahlbom et al. 2001), and serum deprivation (Hammond et al. 2001).”
BackgroundBenten, W. P. M., Lieberherr, M., Stamm, O., Wrehlke, C., Guo, Z., & Wunderlich, F. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.10.3113 · Cited by 253 · cited 1×
“Perhaps most relevant are the observations of Bonni et al. (1999), which indicate that inhibition of CREB activation, a target of MAPK/ERK-Rsk signaling, promotes apoptosis in cerebellar granule cells, whereas Rsk-induced phosphorylation of Bad attenuates Bad-mediated apoptosis, consequently…”
BackgroundIkappa Balpha is a target for the mitogen-activated 90kDa ribosomal S6 kinase
Schouten, G. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3133 · Cited by 225
Transforming Growth Factor-β1 Increases Bad Phosphorylation and Protects Neurons Against Damage
Zhu, Y., Yang, G.-Y., Ahlemeyer, B., Pang, L., Che, X.-M., Culmsee, C., Klumpp, S., & Krieglstein, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03898.2002 · Cited by 224 · cited 5×
“ERK phosphorylation can increase cell viability via activation of p90 kDa ribosomal S6 kinase (Rsk), and subsequent phosphorylation and inactivation of pro-apoptotic factor Bcl-2 associated death protein (Bad) (Zhu et al. 2002).”
BackgroundResultInfluentialEldar-Finkelman, H., Seger, R., Vandenheede, J. R., & Krebs, E. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.987 · Cited by 214 · cited 2×
“1997), and glycogen synthase kinase-3 (Eldar-Finkelman et al. 1995).”
BackgroundLeranth, C., Hajszan, T., & MacLusky, N. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4516-03.2004 · Cited by 208 · cited 1×
“In adult animals, androgens have been linked to neuronal plasticity in the spinal nucleus of the bulbocavernosus (Matsumoto and Prins 2002) as well as regulation of spine synapse density in the CA1 region of hippocampus (Leranth et al. 2004).”
BackgroundTestosterone attenuates β-amyloid toxicity in cultured hippocampal neurons
Pike, C. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03024-4 · Cited by 200 · cited 7×
“…are AR dependent Because pharmacological AR antagonists also can exhibit agonist properties (Maness et al. 1998) including neuroprotection (Pike 2001), we opted against this strategy to investigate whether the androgen-induced actions of MAPK/ERK signaling and neuroprotection require AR.”
BackgroundSelf-citationDifferential Effects of Estradiol and Estradiol-BSA Conjugates
Stevis, P. E. (1999) · Endocrinology · doi:10.1210/en.140.11.5455 · Cited by 197
Age-Related Testosterone Depletion and the Development of Alzheimer Disease
Rosario, E. R. (2004) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.292.12.1431-b · Cited by 193
Sala, C., Rudolph-Correia, S., & Sheng, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03529.2000 · Cited by 189 · cited 2×
“2001), neuronal differentiation (Qui and Green 1992), development (Sala et al. 2000), synaptic plasticity (Krapivinsky et al.”
BackgroundManess, S. C., McDonnell, D. P., & Gaido, K. W. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8431 · Cited by 188
Bajetto, A., Barbero, S., Bonavia, R., Piccioli, P., Pirani, P., Florio, T., & Schettini, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00350.x · Cited by 186
Serum total testosterone is lower in men with Alzheimer's disease.
Hogervorst, E., Williams, J. H., Budge, M., Barnetson, L. P. D., Combrinck, M. I., & Smith, A. D. (2001) · PubMed · Cited by 177
Morley, J. E. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00192-4 · Cited by 177
Yang, S.-H., Perez, E., Cutright, J., Liu, R., He, Z., Day, A. L., & Simpkins, J. W. (2002) · Journal of Applied Physiology · doi:10.1152/jappl.2002.92.1.195 · Cited by 146
Zhang, Y. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0913-04.2004 · Cited by 138 · cited 1×
“Recent data suggest androgen neuroprotection may involve increased levels of heat shock protein 70 (Zhang et al. 2004), possibly the result of androgen-mediated transcriptional activation.”
BackgroundAndrogens modulate β‐amyloid levels in male rat brain
Ramsden, M., Nyborg, A. C., Murphy, M. P., Chang, L., Stanczyk, F. Z., Golde, T. E., & Pike, C. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02114.x · Cited by 135
Self-citationLabombarda, F., Gonzalez, S. L., Deniselle, M. C. G., Vinson, G. P., Schumacher, M., De Nicola, A. F., & Guennoun, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02055.x · Cited by 123 · cited 1×
“(2005) 94, 1639–1651 AR cell cultures, neuroprotective androgen signaling via the MAPK/ERK pathway does not appear to involve cell surface-associated hormone receptors, as has been suggested for estrogen (Guerra et al. 2004) and progesterone (Labombarda et al. 2003).”
BackgroundTestosterone signaling in T cells and macrophages
Wunderlich, F. T., Benten, W. P. M., Lieberherr, M., Guo, Z., Stamm, O., Wrehlke, C., Sekeris, C. E., & Mossmann, H. (2002) · Steroids · doi:10.1016/s0039-128x(01)00175-1 · Cited by 115 · cited 1×
“…as well as utilize second messenger systems such as cyclic adenosine 3¢,5¢-monophosphate (Rubin et al. 1999), inositol 1,4,5-trisphosphate (Lieberherr and Grosse 1994), phospholipase C (Benten et al. 1999), 1,2-diacylglycerol (Lieberherr and Grosse 1994), and calcium (Wunderlich et al. 2002).”
BackgroundAndrogens modulate neuronal vulnerability to kainate lesion
Ramsden, M., Shin, T. M., & Pike, C. J. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.048 · Cited by 113 · cited 3×
“(2005) 94, 1639–1651 2001; Ramsden et al. 2003a) and Ab (Ramsden et al. 2003b), the protein implicated as a causal factor in AD pathogenesis (Selkoe 1999).”
BackgroundSelf-citationOvarian hormones after postnatal day 20 reduce neuron number in the rat primary visual cortex
Nuñez, J. L., Sodhi, J., & Juraska, J. M. (2002) · Journal of Neurobiology · doi:10.1002/neu.10092 · Cited by 102
Wong, J. K., Le, H. H., Zsarnovszky, A., & Belcher, S. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04984.2003 · Cited by 100 · cited 1×
“However, Wong et al. (2003) found that testosterone, unlike estrogen, does not increase ERK phosphorylation in cerebellar granule cells.”
BackgroundGoodenough, S., Engert, S., & Behl, C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01622-0 · Cited by 98 · cited 2×
“However, as testosterone is metabolized in brain to estradiol and DHT, neural actions of testosterone such as neuroprotection and regulation of Ab can be mediated through both estrogen- (Goodenough et al. 2000; Azcoitia et al. 2001) and androgen- (Hammond et al.”
BackgroundNongenomic Testosterone Calcium Signaling
Guo, Z., Benten, W. P. M., Krücken, J., & Wunderlich, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202997200 · Cited by 90
Guerra, B., Díaz, M., Alonso, R., & Marin, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02695.x · Cited by 83 · cited 2×
“AR cell cultures, neuroprotective androgen signaling via the MAPK/ERK pathway does not appear to involve cell surface-associated hormone receptors, as has been suggested for estrogen (Guerra et al. 2004) and progesterone (Labombarda et al.”
BackgroundNishino, H., Nakajima, K., Kumazaki, M., Fukuda, A., Muramatsu, K., Deshpande, S. B., Inubushi, T., Morikawa, S., Borlongan, C. V., & Sanberg, P. R. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00010-8 · Cited by 72 · cited 1×
“In addition to these in vitro studies, in vivo observations show that androgens can improve neuron survival in response to some (Ramsden et al. 2003a) but not all (Nishino et al. 1998; Yang et al. 2002) forms of injury.”
BackgroundPurves-Tyson, T. D., & Keast, J. R. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.019 · Cited by 54
Method for evaluation of the emissivity spectrum of a localized vibrational absorption band
Oheda, H. (2002) · Journal of Applied Physics · doi:10.1063/1.1486251 · Cited by 40
Matsumoto, A., & Prins, G. S. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10112 · Cited by 20
Rubín, J., Hidalgo, A., Bordallo, C., Cantabrana, B., & Sánchez, M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00334-3 · Cited by 17
Cited by
Protective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
Self-citationNon-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493
“Androgens, including T and DHT, can protect neurons from various insults in culture, including kainic acid toxicity [161], β-amyloid toxicity [162; 163] and serum deprivation [164], and have been shown to rapidly activate the cytoprotection-associated ERK/MAPK pathway [161; 163].”
BackgroundSpritzer, M. D., & Galea, L. A. M. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20457 · Cited by 277
Snyder, H. M., Asthana, S., Bain, L., Brinton, R., Craft, S., Dubal, D. B., Espeland, M. A., Gatz, M., Mielke, M. M., Raber, J., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.004 · Cited by 262
Gender, sex steroid hormones, and Alzheimer’s disease
Vest, R. S., & Pike, C. J. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.04.006 · Cited by 260
Self-citation
Metadata
- Authors
- Nguyen, T. V., Yao, M., & Pike, C. J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2005-08-08
- Volume
- 94
- Issue
- 6
- Pages
- 1639-1651
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2039955270
- Cited by
- 182
- References
- 58
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.